The ANKH ΔE490Mutation in Calcium Pyrophosphate Dihydrate Crystal Deposition Disease (CPPDD) Affects Tissue Non-specific Alkaline Phosphatase (TNAP) Activities

John Wang1, Hing Wo Tsui1, Frank Beier2, Kenneth P.H. Pritzker3, Robert D. Inman1, 4, Florence W.L. Tsui* , 1, 4
1 Genetics and Development Division, Toronto Western Research Institute, Canada
2 Department of Physiology and Pharmacology, University of Western Ontario, Canada
3 Pathology and Laboratory Medicine, Mount Sinai Hospital, Canada
4 Department of Immunology, University of Toronto, Canada

Article Metrics

CrossRef Citations:
Total Statistics:

Full-Text HTML Views: 2157
Abstract HTML Views: 1660
PDF Downloads: 449
Total Views/Downloads: 4269
Unique Statistics:

Full-Text HTML Views: 1061
Abstract HTML Views: 999
PDF Downloads: 314
Total Views/Downloads: 2377

Creative Commons License
Bentham Science Publishers Ltd.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited.

* Address correspondence to this author at the Toronto Western Hospital, Mc 14-419, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada; Tel 416-603-5012; Fax: 416-603-5745; E-mail:


ANKH (human homolog of progressive ankylosis) regulates inorganic pyrophosphate (PPi) transport. Dominant ANKH mutations were detected in at least five multiplex families with calcium pyrophosphate dihydrate crystal deposition disease (CPPPD). The objective of this study is to assess the functional consequences of one CPPDD-associated ANKH mutation (ΔE490) in chondrogenic ATDC5 cells. Stable ATDC5 transfectants bearing myc-tagged constructs of wild-type ANKH, mutant ANKH (ΔE490) and neo controls were generated. Upon ITS (insulin, transferrin and selenium) induction, expression of chondrocyte markers including alkaline phosphatase activity in the various transfectants was assessed. The ANKH ΔE490- transfectants had low alkaline phosphatase activities throughout ITS treatment due to lower TNAP protein expression and the presence of intracellular low-molecular-weight inhibitors. Our results suggest that the interplay of ANKH and TNAP activities is tightly regulated.